Analytical Data
-
Gene name
VGLL1
- Application
-
Alternative Names
Protein TONDU; TDU; TONDU; Transcription cofactor vestigial like Protein 1; Transcription cofactor vestigial-like Protein 1; Vestigial like 1; vestigial like 1 homolog (Drosophila); Vgl-1; VGL1; Vgll1; VGLL1_HUMAN
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q99990
-
Expression Region
1-258 aa
-
AA Sequence
MEEMKKTAIR LPKGKQKPIK TEWNSRCVLF TYFQGDISSV VDEHFSRALS NIKSPQELTP SSQSEGVMLK NDDSMSPNQW RYSSPWTKPQ PEVPVTNRAA NCNLHVPGPM AVNQFSPSLA RRASVRPGEL WHFSSLAGTS SLEPGYSHPF PARHLVPEPQ PDGKREPLLS LLQQDRCLAR PQESAARENG NPGQIAGSTG LLFNLPPGSV HYKKLYVSRG SASTSLPNET LSELETPGKY SLTPPNHWGH PHRYLQHL
-
Molecular Weight
28.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
VGLL1 (Vestigial-like 1) is a crucial transcriptional co-regulator that plays a significant role in various biological processes, including cell proliferation, differentiation, and cancer progression. This protein interacts with several transcription factors and signaling pathways, thereby influencing gene expression. Research has increasingly focused on VGLL1 due to its potential implications in cancer biology, particularly in breast cancer and other malignancies where its expression levels are often dysregulated. The study of VGLL1 and its recombinant protein forms is essential for understanding its functional mechanisms and interactions within cellular contexts. By generating VGLL1 recombinant proteins, researchers aim to elucidate its role in transcriptional regulation and to explore its potential as a therapeutic target. Additionally, analyzing the effects of VGLL1 on downstream signaling pathways and its interplay with other proteins can provide insights into its contribution to tumorigenesis and metastasis. Thus, the investigation of VGLL1 recombinant protein not only enhances our understanding of fundamental biological processes but also holds promise for developing novel strategies in cancer treatment and management.
